Researchers conducted a retrospective study with 88 patients who underwent liver resection for hepatic alveolar echinococcosis. They found that monitoring anti-recEm18 antibody levels was a valuable tool for post-surgical surveillance. Specifically, patients with elevated preoperative anti-recEm18 values can rely on this marker to confirm the success of curative surgery at the 12-month follow-up, enabling effective long-term monitoring and reducing the clinical challenges associated with disease recurrence.
Journal Article by Gloor S, Jiang W (…) Beldi G et 8 al. in HPB (Oxford)
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.